A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

says she was told that the tumor was, in fact, cancerous. Specifically, it was mucinous ovarian cancer, which the University of Chicago Medicine explains is a rare subtype of cancer where the ...

Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...

Oregon State University scientists have developed a highly efficient, uniquely shaped magnetic nanoparticle that could enable ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...